Form 4: Integra LifeSciences Director Christian S. Schade Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Christian S. Schade reports changes in beneficial ownership of Integra LifeSciences common stock, including acquisition of 8,696 shares and disposal of an unspecified amount on May 9, 2024.
Summary
- On May 9, 2024, Christian S. Schade, a director of Integra LifeSciences Holdings Corp, reported a transaction involving the company's common stock.
- Schade acquired 8,696 shares of common stock.
- Schade also disposed of an unspecified amount of common stock.
- Following these transactions, Schade beneficially owns 63,503 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company directors.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of stock acquisition and disposal transaction. |
| 05/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.